These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25086953

  • 21. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
    [Abstract] [Full Text] [Related]

  • 22. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K.
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [Abstract] [Full Text] [Related]

  • 23. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM.
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [Abstract] [Full Text] [Related]

  • 24. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
    Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA.
    Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
    [Abstract] [Full Text] [Related]

  • 25. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, Uzan C, Lumbroso S, Lecuru F, Bats AS, Ghazzar N, Bannier M, Houvenaeghel G, Brenot-Rossi I, Narducci F.
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [Abstract] [Full Text] [Related]

  • 26. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [Abstract] [Full Text] [Related]

  • 27. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
    Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K.
    Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
    [Abstract] [Full Text] [Related]

  • 29. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L, Chen Y, Wu J.
    Hell J Nucl Med; 2013 May; 16(3):230-6. PubMed ID: 24137577
    [Abstract] [Full Text] [Related]

  • 30. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    Albano D, Patti C, La Grutta L, Agnello F, Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M, Galia M.
    Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
    [Abstract] [Full Text] [Related]

  • 31. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A, Monnier S, Becker CD, Montet X, Delattre BM, Ratib O, Garibotto V, Tabouret-Viaud C.
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [Abstract] [Full Text] [Related]

  • 32. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
    Punwani S, Taylor SA, Bainbridge A, Prakash V, Bandula S, De Vita E, Olsen OE, Hain SF, Stevens N, Daw S, Shankar A, Bomanji JB, Humphries PD.
    Radiology; 2010 Apr; 255(1):182-90. PubMed ID: 20308456
    [Abstract] [Full Text] [Related]

  • 33. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L.
    Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
    [Abstract] [Full Text] [Related]

  • 34. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
    Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, Ahlström H.
    Acta Radiol; 2011 Mar 01; 52(2):173-80. PubMed ID: 21498346
    [Abstract] [Full Text] [Related]

  • 35. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA, Lilienstein J, Gönen M, Maragulia J, Moskowitz CH, Zelenetz AD.
    J Clin Oncol; 2014 Jan 01; 32(1):51-6. PubMed ID: 24248697
    [Abstract] [Full Text] [Related]

  • 36. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
    Platzek I.
    PET Clin; 2016 Oct 01; 11(4):363-73. PubMed ID: 27593243
    [Abstract] [Full Text] [Related]

  • 37. [The role of FDG-PET in staging of lymphoma and evaluation of therapeutic efficiency].
    Zhou LL, Wang C, Zhao JH, Yan SK, Gao YR, Cai Q, Jiang JL, Wan LP, Yang J, Wei J, Zhao M, Bai HT.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr 01; 30(4):233-6. PubMed ID: 19731822
    [Abstract] [Full Text] [Related]

  • 38. PET/MRI for the evaluation of patients with lymphoma: initial observations.
    Heacock L, Weissbrot J, Raad R, Campbell N, Friedman KP, Ponzo F, Chandarana H.
    AJR Am J Roentgenol; 2015 Apr 01; 204(4):842-8. PubMed ID: 25794075
    [Abstract] [Full Text] [Related]

  • 39. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
    Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Kassai Y, Yui M, Matsumoto S, Sugimura K.
    Eur J Radiol; 2015 Nov 01; 84(11):2321-31. PubMed ID: 26231045
    [Abstract] [Full Text] [Related]

  • 40. Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
    Hu YY, Zhang X, Long W, Lin XP, Zhang YR, Li YH, Xiao ZZ, Zheng RL, Liang PY, Fan W.
    Eur J Radiol; 2015 Jul 01; 84(7):1378-82. PubMed ID: 25882963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.